Stockreport

Genmab: Multiple Binaries Could Alter The Thesis [Seeking Alpha]

Genmab A/S - American Depositary Shares  (GMAB) 
PDF Upcoming registrational readouts for EPKINLY, Rina-S, and petosemtamab in 2026–2027 could drive multi-billion-dollar peak sales and diversify GMAB's revenue base. GMA [Read more]